Global Systemic Radiotherapy Market Research Report
- Report Code: SY 1000
- Publish Date: Upcoming
The Global Systemic Radiotherapy Market, driven by rapidly changing cancer treatment technology and Growing number of cancer patients and mainly its applications in thyroid cancer, bone metastasis, radio immunotherapy and non-Hodgkin’s lymphoma, was pegged at $436.5 million in 2013 and expected to be $527 million by 2018, growing at a CAGR of 3.8%. The Systemic Radiotherapy Market is the lowest segment of $436.5 million Radiotherapy Devices market.
The report “Systemic Radiotherapy Market forecast, 2012-2018 “analyzes the market of devices by 5 segments such as Iodine-131, Samarium-153, Rhenium-186, Erbium-169 and Yttrium-90.These radiation sources are generally applied in combination with chemotherapy for the cancer treatment. Among these sources, I-131 is the most preferred isotope to other sources. With a Market Value of $262 million and $186 million, Gamma Knife and Cyber Knife segments have been contributing 48% and 34% in terms of total Systemic Radiotherapy Market. Both the markets have been witnessing maximum growth because of increase in Cancer patient pool.
Types of this market are Intravenous administration and Oral administration. Systemic Radiotherapy is generally used in combination with radiosurgery, general surgery or External beam radiotherapy for non-systemic Cancers.
In North America (US, Canada), Europe (Germany, France, Italy, Spain, UK), and Asia (India, China, Japan) the rising rates of Cancer population have been driving the Market growth. The Market growth is significantly higher in North America because it is always inclined to the newer techniques while comparatively slow-moving markets such as Europe and Japan are maturing with both old and new technologies. North America is the most dynamic, highly competitive and the largest market for radiotherapy devices globally.
This entire systemic radiation therapy device market holds a minor share in the global radiotherapy market due to its new entry in this market and highly expensive treatment procedure compared to existing treatment alternatives. There are a few procedures for the treatment of blood borne and bone cancer. As these radio sources are transported through blood stream, it is often considered as the gold standard for blood and bone cancers as these radio sources are transported through blood.
The report also provides an extensive competitive landscaping of companies operating in this market. The main companies operating in Internal Beam Radiotherapy Market and extensively covered in this report are Nordion, IBA SA, Polatum, Eckert & Ziegler BEBIG SA.
Segment and country specific Company shares, News & Deals, M&A, segment specific pipeline products, product approvals and product recalls of the major companies have been detailed.
Customization Options:
With Market data, you can also customize MMM assessments that meet your Company’s specific needs. Customize to get comprehensive industry standard and deep dive analysis of the following parameters:
Product Analysis
- Usage pattern (in-depth trend analysis) of products (Segment wise)
- Product Matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub segment level
- End-user Adoption rate analysis of the products (Segment wise and Country wise)
- Comprehensive coverage of Product approvals, Pipeline products and Product recalls
Epidemiology Data
- Country specific Prevalence of Prostate Cancer, Breast and female genital organs Cancers, Cervical Cancer and Penile Cancer, and non-Hodgkin’s lymphoma
- Country specific Patient pool of Prostate Cancer, Breast and female genital organs Cancers, Cervical Cancer and Penile Cancer, and non-Hodgkin’s lymphoma
- Disease progression (Pattern analysis)
Procedure Volume Data
- Number of Prostate Cancer, Breast and female genital organs Cancers, Cervical Cancer and Penile Cancer, and non-Hodgkin’s lymphoma Surgeries performed annually in each Country tracked till sub-segment level.
Surgeons/Physicians Perception Analysis
- Fast turn-around analysis of Surgeons response to market events and trends
- Surgeons opinion about products from different companies
- Surgeons qualitative inputs on epidemiology data
Brand/ Product Perception Matrix
- Comprehensive study of customers perception and behavior through our inbuilt social connect tool checking the virality and tonality of blogs
- Analysis of overall brand usage and familiarity and brand advocacy distribution (Detractor/Neutral/Familiar)
Pricing Trends
- Cost Analysis of Radiotherapy Devices in Various Countries.
- Prostate Cancer, Breast and female genital organs Cancers, Cervical Cancer and Penile Cancer, and non-Hodgkin’s lymphoma procedural investment in major countries.
Competitive Intelligence
- The company share analysis of Radiotherapy devices for the top players of the market in the region.
- The crucial developments and strategies of companies inculcating in their portfolio for Systemic Radiotherapy Devices.
1 Introduction
1.1 Analyst Insights
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
2 Executive Summary
3 Market Overview
4 By Applications
4.1 Prostate Cancer
4.2 Breast and female genital organs Cancers
4.3 Cervical Cancer
4.4 Penile Cancer
4.5 Lung and pleura Cancers
4.6 Esophageal Cancer
4.7 Head and neck cancers
4.8 Colorectal Cancer
4.9 Spine Cancer
5 By Types
5.1 Intravenous administration
5.2 Oral administration
6 By Products
6.1 Iodine-131
6.2 Samarium-153
6.3 Rhenium-186
6.4 Erbium-169
6.5 Yttrium-90
7 By Geographies
7.1 North America
7.2 Europe
7.3 Asia
7.4 Rest of World
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
|
|
North American Systemic Radiotherapy Market The North American Systemic Radiotherapy Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients and mainly its applications in thyroid cancer, bone metastasis, radio immunotherapy and non-Hodgkin’s lymphoma.The Market was pegged at $203.6 million in 2013 and expected to be $248.2 million by 2018, growing at a CAGR of 3.3%.The Systemic Radiotherapy Market analyzes the market of devices by 5 segments such as Iodine-131, Samarium-153, Rhenium-186, Erbium-169 and Yttrium-90.The prominent players in the Systemic Radiotherapy Devices Market globally are Nordion, IBA SA, Polatum, Eckert & Ziegler BEBIG SA. |
Upcoming |
|
|
North America Systemic Radiotherapy Peers of Hydrocolloids are Iodine-131, Samarium-153, Rhenium-186 and Erbium-169 comprising respectively of the Global Systemic Radiotherapy market. It is segmented on basis of . What makes our report unique? You can... |
Upcoming |
|
|
European Systemic Radiotherapy Market The European Systemic Radiotherapy Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients and mainly its applications in thyroid cancer, bone metastasis, radio immunotherapy and non-Hodgkin’s lymphoma.The Market was pegged at $87.5 million in 2013 and expected to be $102.8 million by 2018, growing at a CAGR of 3.3%.The Systemic Radiotherapy Market analyzes the market of devices by 5 segments such as Iodine-131, Samarium-153, Rhenium-186, Erbium-169 and Yttrium-90.The prominent players in the Systemic Radiotherapy Devices Market globally are Nordion, IBA SA, Polatum, Eckert & Ziegler BEBIG SA. |
Upcoming |
|
|
Asian Systemic Radiotherapy Market The Asian Systemic Radiotherapy Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients and mainly its applications in thyroid cancer, bone metastasis, radio immunotherapy and non-Hodgkin’s lymphoma.The Market was pegged at $87.5 million in 2013 and expected to be $102.8 million by 2018, growing at a CAGR of 3.3%.The Systemic Radiotherapy Market analyzes the market of devices by 5 segments such as Iodine-131, Samarium-153, Rhenium-186, Erbium-169 and Yttrium-90.The prominent players in the Systemic Radiotherapy Devices Market globally are Nordion, IBA SA, Polatum, Eckert & Ziegler BEBIG SA. |
Upcoming |
